dilactide has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Z; Liu, J; Shu, M; Su, M; Xie, J; Zeng, Q | 1 |
| Abdel-Bar, HM; Akhtar, M; Al-Jamal, KT; Faruqu, FN; Garnaik, B; Giram, PS; Han, S; Rade, PP; Walters, AA; Wang, JT | 1 |
2 other study(ies) available for dilactide and Colonic Neoplasms
| Article | Year |
|---|---|
Enzymatic synthesis of PEGylated lactide-diester-diol copolyesters for highly efficient targeted anticancer drug delivery.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dioxanes; Docetaxel; Drug Carriers; Drug Compounding; Female; Folic Acid; Mice; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Xenograft Model Antitumor Assays | 2020 |
Green synthesis of methoxy-poly(ethylene glycol)-block-poly(l-lactide-co-glycolide) copolymer using zinc proline as a biocompatible initiator for irinotecan delivery to colon cancer in vivo.
Topics: Colonic Neoplasms; Dioxanes; Drug Carriers; Humans; Irinotecan; Nanoparticles; Particle Size; Pharmaceutical Preparations; Polyethylene Glycols; Proline; Zinc | 2021 |